Address And Details

2005 Market St. , Philadelphia, PA 19103
Fund Manager Jonas Krumplys
Manager Tenure 7 Years 6 Months

Strategy And Objective

To seek to provide growth of capital. Ivy Emerging Markets Equity Fund invests, under normal circumstances, at least 80% of its net assets in equity securities, primarily common stock, of companies (i) from countries considered to be emerging market countries or (ii) that are economically linked to emerging market countries. Emerging market countries include, but are not limited to, those considered to be developing by the International Monetary Fund, the World Bank, the International Finance Corporation or one of the leading global investment banks. IICO has broad discretion to identify other countries that it considers to qualify as emerging market countries. The majority of these countries are likely to be located in Asia, Latin America, the Middle East, Central and Eastern Europe, and Africa. The Fund may invest in companies of any size and market capitalization and in companies in any industry. The issuer of a security or other investment generally is deemed to be economically linked to a particular country if: (a) the security or other investment is issued or guaranteed by the government of that country or any of its agencies, authorities or instrumentalities; (b) the issuer is organized under the laws of, and maintains a principal office in, that country; (c) the issuer has its principal securities trading market in that country; (d) the issuer derives 50% or more of its total revenues from goods sold or services performed in that country; (e) the issuer has 50% or more of its assets in that country; or (f) the issuer is included in an index which is representative of that country.

Net Asset Value

as of 5:48 PM ET 09/17/2021

Performance

  • 1 Week
  • -1.80%
  • 1 Month
  • +2.89%
  • 3 Months
  • -5.28%
  • 1 Yr Return
  • +19.31%
  • 5 Yr Return
  • +76.54%

Equity Sector Breakdown

Technology 19.84%
Finance 17.02%
IndustrialCyclical 12.58%
RetailTrade 8.30%
NonDurables 6.72%
ConsumerDurables 4.92%
Energy 3.68%
Health 3.62%
Utilities 2.47%
Services 2.05%

Asset Allocation

Asset Type % Of Allocation
Stocks 98.86%
ForeignStocks 90.95%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 57.00 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -0.07 -1.64 -7.55
Beta 0.89 0.85 0.99
R Squared 0.60 0.47 0.49
Std Deviation 21.21 18.64 18.94
Sharpe Ratio 0.78 0.72 n/a

Purchase Information

as of 6:05 PM ET 09/16/2021
Minimum Initial $750
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +21.71%
  • +49.05%
+21.71% +49.05%
3 Year
  • +15.11%
  • +16.12%
+15.11% +16.12%
10 Year
  • +6.55%
  • +5.92%
+6.55% +5.92%
Life Of Fund
  • +5.57%
  • +5.80%
+5.57% +5.80%

Top 10 Holdings

Symbol Company Name % Of Assets
TSM TAIWAN SEMICONDUCTOR MANUFACT 8.03%
067166 SAMSUNG ELECTRONICS CO LTD 6.85%
0700.HK TENCENT HOLDINGS LTD 6.30%
2331.HK LI NING COMPANY LTD 4.89%
YNDX YANDEX NV 2.73%
RLNIY RELIANCE INDUSTRIES LTD 2.67%
BABA ALIBABA GROUP HOLDING LIMITE 2.58%
ICBK.NS ICICI BANK LTD 2.52%
HYMPY HYUNDAI MOTOR CO 2.52%
JD JD COM INC 2.48%

LATEST NEWS

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.